Literature DB >> 30235000

The Effect of Digital Breast Tomosynthesis Adoption on Facility-Level Breast Cancer Screening Volume.

Christoph I Lee1,2,3,4,5,6,7,8,9,10, Weiwei Zhu1,2,3,4,5,6,7,8,9,10, Tracy L Onega1,2,3,4,5,6,7,8,9,10, Jessica Germino1,2,3,4,5,6,7,8,9,10, Ellen S O'Meara1,2,3,4,5,6,7,8,9,10, Constance D Lehman1,2,3,4,5,6,7,8,9,10, Louise M Henderson1,2,3,4,5,6,7,8,9,10, Jennifer S Haas1,2,3,4,5,6,7,8,9,10, Karla Kerlikowske1,2,3,4,5,6,7,8,9,10, Brian L Sprague1,2,3,4,5,6,7,8,9,10, Garth H Rauscher1,2,3,4,5,6,7,8,9,10, Anna N A Tosteson1,2,3,4,5,6,7,8,9,10, Jennifer Alford-Teaster1,2,3,4,5,6,7,8,9,10, Karen J Wernli1,2,3,4,5,6,7,8,9,10, Diana L Miglioretti1,2,3,4,5,6,7,8,9,10.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether digital breast tomosynthesis (DBT) adoption was associated with a decrease in screening mammography capacity across Breast Cancer Screening Consortium facilities, given concerns about increasing imaging and interpretation times associated with DBT. SUBJECTS AND METHODS: Facility characteristics and examination volume data were collected prospectively from Breast Cancer Screening Consortium facilities that adopted DBT between 2011 and 2014. Interrupted time series analyses using Poisson regression models in which facility was considered a random effect were used to evaluate differences between monthly screening volumes during the 12-month preadoption period and the 12-month postadoption period (with the two periods separated by a 3-month lag) and to test for changes in month-to-month facility-level screening volume during the preadoption and postadoption periods.
RESULTS: Across five regional breast imaging registries, 15 of 83 facilities (18.1%) adopted DBT for screening between 2011 and 2014. Most had no academic affiliation (73.3% [11/15]), were nonprofit (80.0% [12/15]), and were general radiology practices (66.7% [10/15]). Facility-level monthly screening volumes were slightly higher during the postadoption versus preadoption periods (relative risk [RR], 1.09; 95% CI, 1.06-1.11). Monthly screening volumes remained relatively stable within the preadoption period (RR, 1.00 per month; 95% CI 1.00-1.01 per month) and the postadoption period (RR, 1.00; 95% CI, 1.00-1.01 per month).
CONCLUSION: In a cohort of facilities with varied characteristics, monthly screening examination volumes did not decrease after DBT adoption.

Entities:  

Keywords:  breast cancer screening; capacity; digital breast tomosynthesis; technology adoption

Mesh:

Year:  2018        PMID: 30235000      PMCID: PMC6438161          DOI: 10.2214/AJR.17.19350

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  22 in total

1.  Segmented regression analysis of interrupted time series studies in medication use research.

Authors:  A K Wagner; S B Soumerai; F Zhang; D Ross-Degnan
Journal:  J Clin Pharm Ther       Date:  2002-08       Impact factor: 2.512

2.  Professional and economic factors affecting access to mammography: a crisis today, or tomorrow? Results from a national survey.

Authors:  Dione M Farria; Maria E Schmidt; Barbara S Monsees; Robert A Smith; Charles Hildebolt; Roberta Yoffie; Debra L Monticciolo; Stephen A Feig; Lawrence W Bassett
Journal:  Cancer       Date:  2005-08-01       Impact factor: 6.860

Review 3.  Reported drop in mammography : is this cause for concern?

Authors:  Nancy Breen; Kathleen A Cronin; Helen I Meissner; Stephen H Taplin; Florence K Tangka; Jasmin A Tiro; Timothy S McNeel
Journal:  Cancer       Date:  2007-06-15       Impact factor: 6.860

4.  Understanding pathways for scaling up health services through the lens of complex adaptive systems.

Authors:  Ligia Paina; David H Peters
Journal:  Health Policy Plan       Date:  2011-08-05       Impact factor: 3.344

5.  Disparities in screening mammography services by race/ethnicity and health insurance.

Authors:  Garth H Rauscher; Kristi L Allgood; Steve Whitman; Emily Conant
Journal:  J Womens Health (Larchmt)       Date:  2011-09-23       Impact factor: 2.681

6.  Advanced Breast Imaging Availability by Screening Facility Characteristics.

Authors:  Christoph I Lee; Andy Bogart; Rebecca A Hubbard; Eniola T Obadina; Deirdre A Hill; Jennifer S Haas; Anna N A Tosteson; Jennifer A Alford-Teaster; Brian L Sprague; Wendy B DeMartini; Constance D Lehman; Tracy L Onega
Journal:  Acad Radiol       Date:  2015-04-04       Impact factor: 3.173

7.  Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program.

Authors:  Per Skaane; Andriy I Bandos; Randi Gullien; Ellen B Eben; Ulrika Ekseth; Unni Haakenaasen; Mina Izadi; Ingvild N Jebsen; Gunnar Jahr; Mona Krager; Loren T Niklason; Solveig Hofvind; David Gur
Journal:  Radiology       Date:  2013-01-07       Impact factor: 11.105

Review 8.  Clinical implementation of digital breast tomosynthesis.

Authors:  Emily F Conant
Journal:  Radiol Clin North Am       Date:  2014-02-18       Impact factor: 2.303

9.  Changes in access to screening mammography, 2008-2011.

Authors:  Elena B Elkin; J Paige Nobles; Laura C Pinheiro; Coral L Atoria; Deborah Schrag
Journal:  Cancer Causes Control       Date:  2013-03-07       Impact factor: 2.506

10.  Mammography capacity impact on screening rates and breast cancer stage at diagnosis.

Authors:  Linda S Elting; Catherine D Cooksley; B Nebiyou Bekele; Sharon H Giordano; Ya Chen Tina Shih; Kelly K Lovell; Elenir B C Avritscher; Richard Theriault
Journal:  Am J Prev Med       Date:  2009-06-12       Impact factor: 5.043

View more
  2 in total

1.  Impact of New Technology Adoption on Breast Cancer Screening.

Authors:  Christoph I Lee; Janie M Lee
Journal:  Radiology       Date:  2018-12-11       Impact factor: 11.105

2.  Comparative Access to and Use of Digital Breast Tomosynthesis Screening by Women's Race/Ethnicity and Socioeconomic Status.

Authors:  Christoph I Lee; Weiwei Zhu; Tracy Onega; Louise M Henderson; Karla Kerlikowske; Brian L Sprague; Garth H Rauscher; Ellen S O'Meara; Anna N A Tosteson; Jennifer S Haas; Roberta diFlorio-Alexander; Celia Kaplan; Diana L Miglioretti
Journal:  JAMA Netw Open       Date:  2021-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.